NGM Biopharmaceuticals Inc (NASDAQ:NGM)
| 5.40 Delayed Data As of Feb 06 |  0.00 / 0.00%Today’s Change | 2.92 Today|||52-Week Range 18.25 | +7.57% Year-to-Date |
Latest NGM News | Press Releases
No recent news for NGM Biopharmaceuticals Inc.
Today’s Trading
| Previous close | 5.40 |
| Today’s open | 5.37 |
| Day’s range | 5.31 - 5.42 |
| Volume | 8,341 |
| Average volume (3 months) | 785,710 |
| Market cap | $441.3M |
Data as of 3:59pm ET, 02/06/2023
Growth & Valuation
| Earnings growth (last year) | -4.30% |
| Earnings growth (this year) | -35.04% |
| Earnings growth (next 5 years) | -- |
| Revenue growth (last year) | -10.86% |
| P/E ratio | NM |
| Price/Sales | 17.53 |
| Price/Book | 1.25 |
Competitors
| ---- | ||
| WVEWAVE Life Sciences L... | -0.07 | -1.36% |
| KODKodiak Sciences Inc | -0.62 | -7.23% |
| PGENPrecigen Inc | +0.09 | +4.92% |
Data as of 4:00pm ET, 02/06/2023
Financials
| Next reporting date | March 1, 2023 |
| EPS forecast (this quarter) | -$0.52 |
| Annual revenue (last year) | $77.9M |
| Annual profit (last year) | -$120.3M |
| Net profit margin | -154.51% |
Profile
Sector Health Technology |
Industry Biotechnology |
No executives to display |
Corporate headquarters South San Francisco, California |
Forecasts
